LYZZ Capital is a leading global healthcare-focused venture capital and private equity firm, managing over USD $600 million in funds. The firm invests in innovative talents, assets, and technologies worldwide, targeting unmet medical needs and significant market opportunities in China. Their portfolio spans healthcare, medical devices, medical services, and medical digitalization sectors.

The management team comprises experienced professionals from leading pharmaceutical and biotech companies, as well as Wall Street firms, with strong scientific and medical backgrounds. They have over 20 years of biotech investment experience, including more than 15 years in China, fostering a collaborative and team-oriented environment.